Display options
Share it on

Curr Obes Rep. 2014 Dec;3(4):387-95. doi: 10.1007/s13679-014-0118-7.

Impact of Adiposity and Fat Distribution on the Dynamics of Adrenocorticotropin and Cortisol Rhythms.

Current obesity reports

Ferdinand Roelfsema, Alberto M Pereira, Johannes D Veldhuis

Affiliations

  1. Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Albinusdreef 2, 2333ZA, Leiden, The Netherlands. [email protected].
  2. Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Albinusdreef 2, 2333ZA, Leiden, The Netherlands.
  3. Endocrine Research Unit, Mayo Medical and Graduate Schools, Clinical Translational Research Center, Mayo Clinic, Rochester, MN, 55901, USA.

PMID: 26626915 DOI: 10.1007/s13679-014-0118-7

Abstract

Obesity impacts many hormonal systems, including pituitary hormones, as well as insulin and leptin. In this review we discuss articles which investigate the influence of obesity on the hypothalamic-pituitary-adrenal (HPA) axis. Different techniques have been used to assess the function of the HPA-axis in obesity, including measuring fasting and/or late evening levels of adrenocorticotropic hormone (ACTH) and (free) cortisol in plasma and saliva, studying feedback with dexamethasone or cortisol, and evaluating responsiveness of the system to corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) or ACTH 1-29. In addition, more elaborate studies investigated 24-h secretion patterns, analyzed with deconvolution techniques to quantitate pulsatile secretion rates of cortisol and less often ACTH. Other investigators used timed infusions of labeled cortisol for the estimation of the 24-h secretion rate, clearance rate and distribution volume. Many studies relied on the 24-h urinary excretion of free cortisol, but for quantitation of the 24-h secretion, measurement of all cortisol-derived metabolites is required. Several studies have applied modern liquid chromatography-tandem-mass spectrometry techniques to measure these metabolites. The picture emerging from all these studies is that, first, ACTH secretion is amplified, likely via enhanced forward drive; and, second, serum cortisol levels are normal or even low, associated with a normal 24-h cortisol secretion per liter distribution volume determined by deconvolution, but enhanced when based on the increased total distribution volume associated with obesity. Increased cortisol secretion was also established by isotope dilution studies and reports based on the measurement of all urinary cortisol metabolites. The responsiveness of the adrenal gland to ACTH is diminished. The studies do not address quantitative aspects of cortisol-cortisone metabolism on individual organs, including liver, central and peripheral fat, intestine, skin, and muscle.

Keywords: Adiposity; Central obesity; Cortisol; Cortisone; Deconvolution; Hypothalamus-pituitary-adrenal axis; Obesity; Rhythms; Steroid metabolism

References

  1. Neuroendocrinology. 2000 Jan;71(1):68-78 - PubMed
  2. J Clin Invest. 1973 Oct;52(10):2617-28 - PubMed
  3. Endocrinology. 2009 Jul;150(7):3083-91 - PubMed
  4. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2297-301 - PubMed
  5. Am J Physiol Endocrinol Metab. 2009 Aug;297(2):E538-44 - PubMed
  6. J Clin Endocrinol Metab. 2005 Nov;90(11):6185-91 - PubMed
  7. J Clin Endocrinol Metab. 1999 Jun;84(6):2140-50 - PubMed
  8. Endocrinology. 1990 Apr;126(4):1880-7 - PubMed
  9. Endocr Rev. 1998 Jun;19(3):269-301 - PubMed
  10. J Clin Endocrinol Metab. 1974 Feb;38(2):313-9 - PubMed
  11. Eur J Neurosci. 1999 May;11(5):1535-44 - PubMed
  12. Eur J Endocrinol. 2002 Mar;146(3):310-8 - PubMed
  13. Comput Biomed Res. 1986 Apr;19(2):170-91 - PubMed
  14. Clin Endocrinol (Oxf). 2004 Jun;60(6):765-72 - PubMed
  15. J Clin Endocrinol Metab. 1993 Aug;77(2):341-6 - PubMed
  16. J Clin Endocrinol Metab. 2011 Sep;96(9):2874-81 - PubMed
  17. Am J Physiol Regul Integr Comp Physiol. 2004 Apr;286(4):R693-8 - PubMed
  18. J Clin Endocrinol Metab. 2001 Nov;86(11):5554-63 - PubMed
  19. J Clin Endocrinol Metab. 1998 Apr;83(4):1247-52 - PubMed
  20. J Clin Endocrinol Metab. 2009 Oct;94(10):4045-52 - PubMed
  21. Am J Physiol. 1988 Jun;254(6 Pt 1):E786-94 - PubMed
  22. J Clin Endocrinol Metab. 2004 May;89(5):2290-300 - PubMed
  23. J Clin Endocrinol Metab. 2009 Apr;94(4):1176-81 - PubMed
  24. Metabolism. 1992 Aug;41(8):882-6 - PubMed
  25. Circulation. 2002 Nov 12;106(20):2533-6 - PubMed
  26. Am J Physiol. 1986 Apr;250(4 Pt 1):E486-93 - PubMed
  27. Obes Res. 2000 Oct;8(7):487-95 - PubMed
  28. Metabolism. 1995 Sep;44(9 Suppl 3):21-3 - PubMed
  29. Diabetes. 2008 Oct;57(10):2652-60 - PubMed
  30. J Clin Endocrinol Metab. 2008 Sep;93(9):3455-61 - PubMed
  31. Neuroendocrinology. 2000 Jun;71(6):366-74 - PubMed
  32. Stat Med. 2002 Aug 30;21(16):2331-44 - PubMed
  33. Methods Enzymol. 2000;321:149-82 - PubMed
  34. Clin Endocrinol (Oxf). 2001 Oct;55(4):447-54 - PubMed
  35. Nat Neurosci. 1998 Jun;1(2):103 - PubMed
  36. Endocr Rev. 2008 Dec;29(7):823-64 - PubMed
  37. J Clin Endocrinol Metab. 2001 Sep;86(9):4109-14 - PubMed
  38. Adv Biochem Psychopharmacol. 1981;28:475-99 - PubMed
  39. J Clin Endocrinol Metab. 2009 Aug;94(8):2991-7 - PubMed
  40. Int J Obes Relat Metab Disord. 1999 Apr;23(4):419-24 - PubMed
  41. Am J Physiol Regul Integr Comp Physiol. 2001 Mar;280(3):R721-9 - PubMed
  42. Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6740-5 - PubMed
  43. Clin Endocrinol (Oxf). 1998 May;48(5):603-12 - PubMed
  44. Endocrinology. 2005 Dec;146(12):5587-95 - PubMed
  45. Diabetes. 2012 Jun;61(6):1357-64 - PubMed
  46. Neurosci Behav Physiol. 2001 May-Jun;31(3):237-42 - PubMed
  47. Endocr Rev. 2004 Oct;25(5):831-66 - PubMed
  48. J Clin Endocrinol Metab. 1998 May;83(5):1806-9 - PubMed
  49. Eur J Endocrinol. 2008 Nov;159(5):561-8 - PubMed
  50. Eur J Endocrinol. 1999 Mar;140(3):192-200 - PubMed
  51. Diabetes. 1997 Jul;46(7):1235-8 - PubMed
  52. Obes Res. 2004 Sep;12(9):1421-5 - PubMed
  53. Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E848-56 - PubMed
  54. J Clin Endocrinol Metab. 2007 Nov;92(11):4199-207 - PubMed
  55. Obes Res. 2005 Jul;13(7):1157-66 - PubMed
  56. J Diabetes Sci Technol. 2010 Sep 01;4(5):1205-13 - PubMed
  57. Eur J Endocrinol. 2008 Nov;159(5):547-54 - PubMed
  58. Eur J Endocrinol. 1997 Apr;136(4):394-400 - PubMed
  59. J Clin Endocrinol Metab. 2009 Jun;94(6):2137-43 - PubMed
  60. J Clin Endocrinol Metab. 2001 Jan;86(1):151-7 - PubMed
  61. J Clin Endocrinol Metab. 2011 Jan;96(1):115-21 - PubMed
  62. Neuroendocrinology. 1999 Sep;70(3):207-12 - PubMed
  63. Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E218-24 - PubMed
  64. J Clin Endocrinol Metab. 1998 Jun;83(6):1853-9 - PubMed
  65. Horm Metab Res. 2010 Dec;42(13):961-6 - PubMed
  66. Am J Physiol. 1979 Sep;237(3):E255-64 - PubMed
  67. J Clin Endocrinol Metab. 2009 Nov;94(11):4234-42 - PubMed
  68. J Neurosci. 1998 Jan 1;18(1):559-72 - PubMed
  69. J Steroid Biochem. 1975 May;6(5):785-91 - PubMed
  70. Endocrinology. 1998 Oct;139(10):4264-8 - PubMed
  71. Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):4028-33 - PubMed
  72. Anal Biochem. 2008 Oct 1;381(1):8-17 - PubMed
  73. Acta Endocrinol (Copenh). 1966 Feb;51(2):186-92 - PubMed
  74. Metabolism. 1982 Mar;31(3):209-12 - PubMed
  75. J Clin Endocrinol Metab. 2004 Jan;89(1):281-7 - PubMed
  76. Stat Med. 1991 Mar;10(3):329-40 - PubMed
  77. Clin Endocrinol (Oxf). 1988 Jan;28(1):15-8 - PubMed
  78. Diabetes. 1998 Jun;47(6):890-3 - PubMed
  79. J Clin Endocrinol Metab. 2002 Jan;87(1):166-75 - PubMed
  80. Obesity (Silver Spring). 2013 Jan;21(1):E105-17 - PubMed
  81. J Clin Endocrinol Metab. 1999 Mar;84(3):1022-7 - PubMed
  82. Eur J Endocrinol. 2012 Nov;167(5):633-42 - PubMed
  83. Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E652-61 - PubMed
  84. J Nutr. 2000 Nov;130(11):2813-20 - PubMed
  85. Obes Res. 1996 May;4(3):277-82 - PubMed
  86. Metabolism. 1996 Mar;45(3):351-6 - PubMed
  87. J Clin Endocrinol Metab. 2007 Jul;92(7):2468-73 - PubMed

Publication Types